Verastem Inc (NASDAQ:VSTM)
| 7.32 Delayed Data As of Dec 08 |  -0.27 / -3.56%Today’s Change | 3.87 Today|||52-Week Range 15.18 | +51.55% Year-to-Date |
Latest VSTM News | Press Releases
No recent news for Verastem Inc.
Today’s Trading
| Previous close | 7.59 |
| Today’s open | 7.62 |
| Day’s range | 7.32 - 7.71 |
| Volume | 2,086 |
| Average volume (3 months) | 93,912 |
| Market cap | $177.1M |
Data as of 3:59pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | +6.64% |
| Earnings growth (this year) | +25.84% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.47 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NXTCNextCure Inc | +0.10 | +8.00% |
| ---- | ||
| SEELSeelos Therapeutics ... | -0.04 | -2.37% |
| NKTRNektar Therapeutics | -0.00 | -0.30% |
Data as of 3:59pm ET, 12/08/2023
Financials
| Next reporting date | March 12, 2024 |
| EPS forecast (this quarter) | -$0.71 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$73.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Needham, Massachusetts |
Forecasts
